Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Neonmind Biosciences Inc (OP: NMDBF )

N/A UNCHANGED
Last Price Updated: 10:22 AM EST, Dec 14, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Neonmind Biosciences Inc

World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
The Benzinga Psychedelics Advisory Council was introduced in March of 2022 with the sustained goal of better informing investors and general audience about the psychedelics financial and business... 
Via Benzinga
Psyched: Big Pharma's Sanofi Enters Psychedelics Space, DNA From 80 Psilocybe Mushrooms Published Online, Maine Psychedelics Bill Shelved
Benzinga’s first-ever Psychedelics Capital Conference was a colossal success. Over 600 investors, policymakers, industry executives and thought leaders gathered at the Fontainebleau Hotel in Miami... 
Via Benzinga
NeonMind To Improve Patient Care And Data Management With Thrive Health's Digital Healthcare Platform
NeonMind Biosciences Inc. 
Via Benzinga
NeonMind To Launch 10 Mental Health Clinics In Canada, How Will Patients Benefit?
NeonMind Biosciences Inc. (CSE:NEON) (OTCQB: NMDBF) (FRA:6UF) plans to launch 10 specialty mental health clinics over the next 3 years through alliances with SRx Health Solutions and BioScript... 
Via Benzinga
Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space
The psychedelics legislative landscape continues to move forward with Hazel Park,Michiganenacting decriminalization ... 
Via Benzinga
NeonMind Files Provisional Patent Application For Psilocybin Induced Weight Loss
NeonMind Biosciences Inc. (OTCQB: NMDBF) (CSE: NEON) (FRA:6UF) has filed a new patent application with the U.S. Patent and ... 
Via Benzinga
Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial
A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. UsingReal World ... 
Via Benzinga
NeonMind Completes Pre-IND Consultation With FDA And Strengthens Medical Services Division
NeonMind Biosciences Inc.(OTCQB: NMDBF) (CSE: NEON) (FRA:6UF) provided a summary of business highlights on the ... 
Via Benzinga
Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results
On the legislative front of the psychedelics space, a new bill meant to study the therapeutic effects of psychedelic substances ... 
Via Benzinga
NeonMind Teams Up With BioScript Solutions To Expand Its Clinic Network For Interventional Psychiatry Treatments
Psychedelic drug company NeonMind Biosciences Inc. (CSE:NEON)... 
Via Benzinga
Cannabis Movers & Shakers: MedMen, Organigram, NeonMind, Green Check Verified
Former Tilray Exec Ana Bowman Joins MedMen As CFO MedMen Enterprises Inc. (CSE: 
Via Benzinga
NeonMind Appoints Dr. Dinesh Bhayana As Site Medical Director Of Its First Mental Health Clinic
NeonMind Biosciences Inc. (CSE:NEON)(OTCQB: 
Via Benzinga
NeonMind To Open Its First Specialty Mental Health Clinic In Ontario, More To Come
Psychedelics company NeonMind Biosciences Inc. (OTCQB:NMDBF 
Via Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking investors, is coming to the Fontainebleau Miami Beach on April 19, 2022,... 
Via Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
The Week In Psychedelics 
Via Benzinga
How To Invest In "Magic Mushrooms" (Psychedelics)
A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest. 
Via Talk Markets
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S... 
Via Benzinga
Psyched: MindMed, Atai Head For Nasdaq, Psychedelics Search Platforms Grow, Champignon Brands Resumes Trading
Two of the most highly funded companies in the psychedelics space announced plans last week to list on the Nasdaq exchange. Months after ... 
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.